Abstract Objective: To examine the association between the use of drugs with potential hyperglycemic effects and increased HbA1c levels in a very elderly population. Methods: This was a cross-sectional study of older subjects age 81 years and over from the second follow-up (1994-1996) of the Kungsholmen project, a populationbased study of elderly in an urban area of Stockholm, Sweden. The study population consisted of 578 subjects, with a mean age of 86.7 years, without known diabetes mellitus. Glucose levels were assessed using HbA1c. Information on drug use was based on personal interviews. Diagnoses of diabetes mellitus, hypertension, and congestive heart failure were obtained from personal or relative interviews, assessment by the examining physician, and from the computerized inpatient register. Measures of other factors that may influence glucose homeostasis included body mass index, s-K + , s-Ca 2+ , thyroid stimulating hormone, and sedimentation rate. Results: High HbA1c levels (>5.3%) indicating hyperglycemia were seen in 11% of the women and 12% of the men. Use of loop diuretics was significantly associated with high levels of HbA1c in both women and men, even after adjusting for hypertension and congestive heart failure. Eighteen percent of users of loop diuretics had high levels compared with 8% among non-users. Conclusion: Our results indicate that loop diuretics may have hyperglycemic effects in the very elderly. This finding can be of clinical importance as loop diuretics are among the most commonly taken drugs in this population.
Introduction
A large number of drugs, including glucocorticoids, diuretics and b 2 -receptor agonists can cause hyperglycemia in non-diabetic individuals or disturb the metabolic control in diabetic patients [1, 2, 3, 4, 5] . Normal glucose homeostasis is maintained by an interaction between insulin and hormones such as glucagon, catecholamines, growth hormone and cortisol. Possible drug effects on glucose metabolism may occur via any of these factors, either alone or in combination. Also other factors, such as insulin resistance due to concurrent disorders, inherent mechanisms and organ function, may augment the risk of drug-induced impairment of glucose homeostasis in susceptible individuals [6] .
In the Whitehall study, a long-term prospective study of the health of a large number of civil servants [7] , a higher incidence of coronary artery disease was reported in subjects with asymptomatic glucose intolerance than in subjects with normal glucose tolerance. In another 10-year prospective study by Jarret et al. [8] , a higher coronary heart disease mortality rate was found in patients who had glucose intolerance than in normal controls. Thus, the risk of developing large-vessel disease seems to be to some extent associated with glucose intolerance.
Long-term use of thiazides, [9] while reducing mortality from cerebrovascular disease and renal impairment in hypertensive patients, could increase the incidence of coronary vascular disease. A recent prospective study of a population-based cohort of men 60 years and older showed that increase in blood glucose during antihypertensive treatment (mainly beta-blockers and thiazide diuretics) was a significant and independent risk factor for myocardial infarction [10] .
The development of glucose intolerance during longterm diuretic treatment may imply that we erroneously are replacing one long-term cardiovascular risk factor with another. It is therefore important to pay attention to medication with potential hyperglycemic effects, particularly in patients with hypertension in whom other factors such as overweight and low physical activity may predispose them to glucose intolerance. This would be even more important in the elderly, where the prevalence of preexisting cardiovascular disease is high and drugs with potential hyperglycemic effects are frequently used. However the gross effects of drugs on the control of glucose homeostasis have been poorly studied in the very old.
The aim of the present study was to assess the association between the use of drugs with potential hyperglycemic effects and high blood glucose levels in the elderly, using high-glycosylated hemoglobin (HbA1c) levels as an indicator of hyperglycemia. HbA1c is well established as a surrogate marker for the average glucose levels during the last 2-3 months. According to previous studies, HbA1c levels are a useful guide to rational screening and treatment control for diabetes mellitus [11, 12] . This study is based on a population of very old people, 81 years and over, in the Kungsholmen project, a longitudinal population based study of elderly in Stockholm, Sweden.
Materials and methods
The Kungsholmen project has been described in detail previously [13, 14] . The project included all persons registered in a central district of Stockholm, age 75 years and over on 1 October 1987. The baseline data collection was performed between 1987 and 1989.
The present study is based on the second follow-up of the Kungsholmen project, made between 1994 and 1996. The total number of subjects participating was 683. The clinical examination and health interview, including information about drug use, was carried out by a physician. In the majority of cases the interview was made with the subject personally.
The drug data included prescription as well as non-prescription drug use [14] . Both regularly used drugs and drugs used on an as-needed basis were listed. A drug taken regularly was considered to be used if it was used at the time of the interview, a drug taken as needed was recorded if it had been used some time during the two preceding weeks. The name and strength of the medicine, the administration form, and the dosage regime were registered. The drug data were classified according to the Anatomical Therapeutic Chemical classification system [15] . Classification and coding of data was done by an experienced pharmacist.
Housing was classified into three levels: (1) own home, either owned or rented; (2) sheltered accommodation (individual apartments with access to communal facilities with a professional but not medically skilled caregiver); and (3) institution, consisting of nursing homes and geriatric wards.
Information on the subjects' medical diagnoses was obtained from patient and relative interviews, assessment by examining physician, and from the computerized inpatient register, which covers all hospitals in the area of Stockholm from 1969.
Patients with known diabetes mellitus-including those with reported diabetes at patient or relative interview, those who were diagnosed as having diabetes by the examining physician, and those with a recorded diabetes diagnosis in the inpatient register-were excluded, a total of 54 persons. Two patients for whom information on drug use was lacking and 53 subjects with missing HbA1c levels (due to refusal to give blood sample or other reasons) were excluded. The study population thus comprised 578 patients, 448 women and 130 men, mean age 86.7±3.9 years. Table 1 shows the study population characteristics.
HbA1c was analyzed in blood samples collected in connection to the interview. The analysis was performed using the high-performance liquid chromatography technique with a Mono S column [16] . We employed the reference interval 3.9-5.3% (taking into account the age dependence of normal levels of HbA1c in patients aged over 50 years). Thus, hyperglycemia was defined as HbA1c over 5.3%.
In this study, we examined drugs with potential hyperglycemic effects [1, 5] used by more than three persons in the population (Table 2) . According to earlier studies [9, 17] , there are gender differences with respect to drug-induced glucose intolerance (more pronounced in women), we therefore studied men and women separately.
Statistical analysis
Statistical tests were performed using SPSS for Windows (SPSS Inc., 1989-1997). Independent-sample t-tests were performed to compare the HbA1c data between men and women and users and non-users of the studied drugs. Logistic regression was used for analyzing the likelihood of having hyperglycemia (HbA1c >5.3%) when using a drug group. The results were adjusted for age, housing level, the use of other drugs with potential hyperglycemic effects, and for measures of other causes of hyperglycemia, including hypokalemia (K + <3.5 mmol/l), high body mass index (BMI >20 kg/m 2 ), hyperthyroidism (thyroid stimulating hormone <0.4 mU/l), inflammatory processes (increased sedimentation rate >20) and hypercalcemia (Ca 2+ >2.6 mmol/l). In the final analyses, hypertension and congestive heart failure were included in the model. a Diagnoses of congestive heart failure and hypertension were based on patient and relative interviews, assessments by examining physician, and data from the computerized inpatient register The Kungsholmen project was approved by the ethics committee of the Karolinska Institute. Informed consent was obtained for each participant. If an individual was unable to make an informed decision, a proxy consent was requested from a close relative.
Results
The mean HbA1c levels and the frequency of low and high levels in women and men are presented in Table 1 . High levels of HbA1c (>5.3%), indicative of hyperglycemia, were seen in about every tenth individual (women 11%, men 12%). Table 3 presents the mean HbA1c levels with respect to the use of drugs with potential hyperglycemic effects. The use of loop diuretics was associated with significantly higher HbA1c levels in both women and men. Table 4 lists the proportion of users and non-users with high HbA1c levels (>5.3%). The association between drug use and high levels was computed using logistic regression, controlling for age, housing level, and factors that may cause disturbed glucose homeostasis (see Methods). The use of loop diuretics was significantly associated with high HbA1c levels in both women and men. Eighteen percent of female users of loop diuretics had high levels compared with 8% among non-users. In men the prevalence of high levels was 17% in users of loop diuretics compared with 9% in non-users.
Since the use of diuretics is associated with both hypertension and congestive heart failure, which in turn may be associated with insulin resistance, we made an additional analysis for loop diuretics, in which we included these diagnoses in the logistic regression model. The association between the use of loop diuretics and high HbA1c levels remained significant both in women (odds ratio 3.08; 95% confidence interval 1.13, 8.38) and in men (8.48; 1.31, 54.8).
For furosemide, which was the only type of loop diuretic used, we also analyzed the mean HbA1c levels in It was somewhat unexpected to find no significant effects of thiazides and glucocorticoids, which are both known to influence glucose metabolism. We therefore examined the mean doses of these drugs, which were 2.8±0.9 mg (n=15) for bendroflumethazide, 50 mg for hydrochlorothiazide (n=1), 6.4±5.2 mg for prednisolone (n=16), and 1.3±1.5 mg for betamethasone (n=3).
There were no differences in the relative use of thiazides and loop diuretics in subjects without and with known diabetes in our population. Thiazides represented 6.7% and 7.1% of all diuretic users in these groups, respectively. The corresponding rates for loop diuretics were 74% and 82%. Nor was there any major difference in the use of glucocorticoids (4.1% and 3.7%, respectively).
Discussion
In the present study, we have examined how drugs may influence glucose levels in the elderly, as assessed using HbA1c levels. The main result is a significant association between high levels and the use of loop diuretics. To our knowledge, this is the first study to report the influence of drugs on glucose homeostasis in an elderly population.
Since glucose intolerance has been reported to be more frequent in female subjects [9] , we analyzed women It is possible that the hyperglycemia seen in loop diuretic users is mainly caused by the two major indications for diuretic treatment, hypertension, and congestive heart failure, which may both be associated with insulin resistance. We therefore made an additional analysis that adjusted for these diagnoses in the logistic regression model. The association between the use of loop diuretics and high HbA1c levels remained significant for both women and men. Taken together these findings indicate that loop diuretics have a significant hyperglycemic effect in this very old population, independent of the presence of hypertension and congestive heart failure.
Diuretics are known to impair glucose tolerance [18, 19, 20, 21] . The mechanism behind this is considered to be stimulation of prostaglandin E, which decreases or inhibits insulin secretion [22, 23, 24] . In addition, the loop diuretic furosemide has also been shown to inhibit glucose uptake into rat isolated adipocytes by directly inactivating a carrier protein [25] . Thiazides are considered to be more prone than other diuretics to cause hyperglycemia [20] . In this study, we did not observe any significant difference between users and non-users of thiazides, although a tendency towards higher HbA1c levels in thiazide users was seen. This lack of significance could be explained by the low number of thiazide users, only 17 compared with the 177 taking loop diuretics. However, another reasonable explanation is that the thiazide doses, which were generally low, were below the doses producing metabolic effects. It is also possible that the physician avoids prescribing thiazides to elderly persons who are susceptible to the adverse effects on glucose homeostasis. However, this would only be the case with elderly persons with known diabetes. Moreover, we did not find any differences in the use of thiazides and loop diuretics between subjects without or with known diabetes that would support such selective prescribing.
In most cases the hyperglycemic effects of diuretics are slight, although they have been reported to precipitate hyperosmolar non-ketotic diabetic coma [26] . Nevertheless our findings may be of importance, as diuretics are often prescribed for older people. For example, among hospitalized people aged 70 years or more, 28.1% were treated with a diuretic on admission [27] . In the Kungsholmen project, 44% of elderly persons aged 81 years and over were using diuretics [14] .
It is well known that glucocorticoids induce insulin resistance and cause impaired glucose tolerance in many non-diabetic subjects, and worsen glycemic control in diabetics. Glucocorticoids decrease hepatic and extrahepatic insulin sensitivity [28] , enhancing gluconeogenesis, while they decrease peripheral glucose utilization by decreasing the insulin receptor concentration [29] . In our study, there was no significant effect of glucocorticoids on HbA1c levels. The fact that there was no major difference in glucocorticoid use between subjects without and with known diabetes would argue against a selective prescribing of these drugs. However, the lack of effect could be due to the low number of users of these drugs. It is also possible that the glucocorticoid doses were too low to produce any significant effects on glucose metabolism.
This study has some limitations. First, it is crosssectional, and therefore our results cannot prove a causal relationship between drug use and hyperglycemia, even though a close association was seen. Second, only 54 persons were excluded because of known diabetes. This represents a prevalence of 8%, which is considerably lower than the reported prevalence of 20% in people aged 80 years and over in Sweden [30] . The same low prevalence was reported in other studies from the Kungsholmen project, both at baseline (1987-1989; 9.2%) [31] and at third follow-up (1997-1998; 7.4%) [32] . This could imply that our study population includes some individuals with undiagnosed diabetes. It is also possible that the low prevalence is due to selection, in which diabetics are overrepresented among the dropouts particularly at later follow-ups. However, we cannot exclude that we may have missed some diabetes diagnoses from additional sources that we do not have access to, for example general practitioners' records. In any case, even if there are individuals with undiagnosed diabetes or missed diagnoses in our study population, the question remains why these would be overrepresented among the elderly using loop diuretics. As was mentioned above, we did not find any evidence of a selective prescribing of loop diuretics in diabetic subjects. Furthermore, the association between loop diuretic use and high HbA1c levels remained significant when adjusting for the presence of hypertension and congestive heart failure, indicating that our findings are not explained by a higher prevalence of these diseases in subjects with unknown diabetes. It should be pointed out that any risk of side effects should be weighed against the beneficial effects of a drug. The therapeutic value of diuretics in both hypertension and congestive heart failure is indisputable. However, our results indicate that it may be appropriate to more actively monitor the blood glucose levels in elderly using these drugs.
In conclusion, we have found an association between the use of loop diuretics and elevated levels of HbA1c, suggesting a hyperglycemic effect of these drugs, in very elderly persons. As loop diuretics are among the most common drugs used in the elderly, this finding may be clinically important. However, our results are based on observational data from a cross-sectional study and therefore need to be confirmed by longitudinal and randomized controlled studies.
